However, suggested equivalent dosages may help determine the right dosage when switching medications
It can lead to unsafe self-adjusting People take more one week, less the next, trying to find the sweet spot. This increases risk, not safety
Calling it GLP-3 may be convenient for search and marketing, but it is less precise
Semaglutide GLP-1 is an innovative medication originally developed for the treatment of type 2 diabetes and is now often used as an anti-obesity medication for long-term weight management
The research backing retatrutide required significantly more investment than semaglutide development
GLP-1 drugs, short for glucagon-like peptide-1, were developed to manage type 2 diabetes but have gained cultural cachet for their appetite-suppressing, weight-loss effects